Safety and efficacy of vemurafenib in BRAF V600E and BRAF V600K mutation-positive melanoma (BRIM-3): extended follow-up of a phase 3, randomised, open-label study
Titel:
Safety and efficacy of vemurafenib in BRAF V600E and BRAF V600K mutation-positive melanoma (BRIM-3): extended follow-up of a phase 3, randomised, open-label study
Auteur:
McArthur, Grant A Chapman, Paul B Robert, Caroline Larkin, James Haanen, John B Dummer, Reinhard Ribas, Antoni Hogg, David Hamid, Omid Ascierto, Paolo A Garbe, Claus Testori, Alessandro Maio, Michele Lorigan, Paul Lebbé, Celeste Jouary, Thomas Schadendorf, Dirk O'Day, Stephen J Kirkwood, John M. Eggermont, Alexander M Dréno, Brigitte Sosman, Jeffrey A Flaherty, Keith T Yin, Ming Caro, Ivor Cheng, Suzanne Trunzer, Kerstin Hauschild, Axel